Cerebral Palsy | CHOP Research Institute
 

Cerebral Palsy

For 3-months, two programs will be offered that may help babies with cerebral palsy move and use their arms more like other children at an early age.

The purpose of this research study is to look at whether or not a sleep questionnaire can be used on infants 3 to 24 months of age, with or at high-risk of having Cerebral Palsy.

Children between the ages of 4 and 16 years old, both with and without cerebral palsy, may be eligible for the study to help researchers learn if there is a difference in sensory processes.

The purpose of this study is to assess deficits in movement and coordination in children with cerebral palsy (CP) and without.

Published on
Mar 25, 2021
Laura Prosser, PT, PhD, is leading the first longitudinal study of locomotor learning in infants who are at high risk for cerebral palsy.

The Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability — PANDA Mobile App Data Collection study’s goal is to develop an affordable noninvasive easy-to-use tool for early detection of infant neurodevelopmental disabilities so they can receive treatment at an early age.

Improving the safety, quality, and health outcomes of pediatric care through clinical research. PeRC’s mission is to provide the expertise and infrastructure needed to support research within the primary care setting.

The Neuromotor Performance Lab (NMPL) is a destination for innovative study and evaluation of motor performance in infants, children, and adolescents.

Dr. Prosser's research focuses are the development and rehabilitation of movement in children, particularly those with neurological impairments. This includes the investigation of the development of impaired movement, the study of novel motor rehabilitation interventions in children, and the interaction between the processes of neuroplasticity and neuromaturation in sensorimotor systems.

E-mail:
prosserl [at] chop.edu
Published on
May 23, 2017
Caffeine therapy can help premature babies breathe stronger and sooner on their own. When a group of caffeine-treated premature babies reached middle school, the therapy appeared to reduce their risk of motor impairment – building on earlier follow-ups that show the treatment's safety, efficacy, and developmental benefits for the babies at one-and-a-half years old.